• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FLOWONIX MEDICAL, INC. PROMETRA II PROGRAMMABLE PUMP; IMPLANTABLE INFUSION PUMP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FLOWONIX MEDICAL, INC. PROMETRA II PROGRAMMABLE PUMP; IMPLANTABLE INFUSION PUMP Back to Search Results
Model Number 13827
Device Problem Use of Device Problem (1670)
Patient Problem Loss of consciousness (2418)
Event Date 05/15/2023
Event Type  Injury  
Manufacturer Narrative
A review of the device history record, which includes verification of all steps in the manufacturing of the pump, verification of all final testing performed by/on the pump, verification of sterilization, and packaging for subject pump was performed.The review did not identify any non-conformances, issues or capas associated with pump function.Device remains implanted and was not returned for additional evaluation and investigation.The issue was determined to be the result of user error during the refill process.Per the instructions for use of the device, refill errors are known possible risks of use of the device.Internal complaint number:(b)(4).
 
Event Description
Physician contacted technical solutions after a patient was admitted to the er with a loss of consciousness following a refill appointment by their nurse.The doctor contacted technical solutions looking for a representative to inquire the pump to see if it was malfunctioning.Technical solutions asked for more information and the doctor reported that the patient was brought into the er by first responders shortly after a refill appointment for intrathecal fentanyl.It was reported that the patient was administered narcan prior to regaining consciousness.Technical solutions informed the physician that these symptoms were aligned with a pocket fill due to the sudden onset of symptoms.They asked technical solutions for next steps and technical solutions explained how to drain the pump to suspend further therapy.Technical solutions asked the physician to note and share the volume of medication removed from the pump.Technical solution then sent the physician an email with the refill procedure and other pertinent information.Technical solutions mentioned that they would be available via phone call as needed to assist on the draining.Later, an agent covering the issue contacted technical solutions regarding this issue.The agent reported that the managing physician was wondering how the pocket fill could have occurred since the nurse performing the refill had told them that they had felt the pressure when accessing the pump.Technical solutions mentioned that the refill ifu states that 1-2ml should be delivered, medication should be allowed to flow back, 5ml should be delivered, medication should be allowed to flow back, and this process should continue as long as the medication is flowing back.If the needle leaves the reservoir and the procedure is not followed, this could lead to a pocket fill as there was no confirmation the needle stayed in the pump.The agent relayed this to the physician who mentioned that the nurse was able to withdraw an unknown amount of medication from the pocket after the patient began decompensating and a "bubble" was seen above the pump, showing that a pocket fill, or a partial pocket fill, had occurred.Finally, a different physician contacted technical solutions regarding this issue.The physician initially reported that the team working on the patient wanted to decrease the patient's dosage using a programmer at the hospital.However, after looking at the patient's file, they did not wish to proceed with this as the patient is managed by a physician out of network.The physician reported that the patient is stable and doing well, which furthered their belief that changing the patient's dosage was not necessary at this time.Technical solutions let the physician know to call back if anything changes and they need technical assistance to decrease the dosing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMETRA II PROGRAMMABLE PUMP
Type of Device
IMPLANTABLE INFUSION PUMP
Manufacturer (Section D)
FLOWONIX MEDICAL, INC.
500 international drive
suite 200
mount olive NJ 07828
Manufacturer (Section G)
FLOWONIX MEDICAL, INC.
120 forbes blvd
suite 170
mansfield MA 02048
Manufacturer Contact
james bennett
500 international drive
suite 200
mount olive, NJ 07828
9734269229
MDR Report Key16946046
MDR Text Key315381253
Report Number3010079947-2023-00042
Device Sequence Number1
Product Code LKK
UDI-Device Identifier00810335020228
UDI-Public(01)00810335020228(17)210218(10)26323
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P080012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 05/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/17/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/18/2021
Device Model Number13827
Device Catalogue Number13827
Device Lot Number26323
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/15/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/18/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient SexMale
-
-